Literature DB >> 22289793

Extracorporeal therapy in sepsis: are we there yet?

Ashutosh M Shukla1.   

Abstract

The role of extracorporeal therapies (ECTs) in sepsis is unclear and is a strongly debated topic in critical-care medicine. Unfortunately, much of this debate arises because we lack a clear understanding of what defines the stage and severity of the disease, and the pivotal pathophysiological events dictating outcomes. In the absence of this knowledge, ECTs remain among a large group of therapies with high promise but unproven efficacy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289793     DOI: 10.1038/ki.2011.375

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Extracorporeal immune cell therapy of sepsis: ex vivo results.

Authors:  Gerd Klinkmann; Thomas Wild; Benjamin Heskamp; Fanny Doss; Sandra Doss; Lubomir Arseniev; Krasimira Aleksandrova; Martin Sauer; Daniel A Reuter; Steffen Mitzner; Jens Altrichter
Journal:  Intensive Care Med Exp       Date:  2022-06-16

2.  Bioartificial Therapy of Sepsis: Changes of Norepinephrine-Dosage in Patients and Influence on Dynamic and Cell Based Liver Tests during Extracorporeal Treatments.

Authors:  Martin Sauer; Jens Altrichter; Cristof Haubner; Annette Pertschy; Thomas Wild; Fanny Doß; Thomas Mencke; Maren Thomsen; Johannes Ehler; Jörg Henschel; Sandra Doß; Stephanie Koch; Georg Richter; Gabriele Nöldge-Schomburg; Steffen R Mitzner
Journal:  Biomed Res Int       Date:  2016-06-28       Impact factor: 3.411

Review 3.  Multiscale Biofluidic and Nanobiotechnology Approaches for Treating Sepsis in Extracorporeal Circuits.

Authors:  Joo H Kang
Journal:  Biochip J       Date:  2020-03-12       Impact factor: 4.229

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.